Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02279303 · ClinicalTrials.gov registry record · NA

Rx for Better Breast Health

A NA study, sponsored by The University of Texas Health Science Center at San Antonio.

Completed
Registry status
NA
Development phase
153
Enrollment target

NCT02279303: Completed NA study, sponsored by The University of Texas Health Science Center at San Antonio.

NCT02279303 is a NA study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 153 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02279303, a NA study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.

COMPLETED
Registry status
NA
Development phase
153 participants
Enrollment target

Study Summary

This randomized controlled trial will test the impact of a patient-navigated, anti-inflammatory, culinary-based intervention (reinforced by motivational interviewing \[MI\] and tailored newsletters) on obese (body mass index \[BMI\] 30+), early-stage (0-IIIA) breast cancer survivors compared to a control group.

Primary Outcome

The USDA has published dietary intake guidelines for 5 major food groups. We will create a composite score ("yes" vs. "no") describing whether ss achieve designated levels of dietary intake for all five food groups. We will compare proportions of study and control women achieving this target at 12-month follow-up controlling for baseline values.

Interventions

  • BEHAVIORAL Dietary Intervention
  • BEHAVIORAL Dietary Control

Trial Details

FieldValue
Enrollment Target 153 participants
Start Date 2013-04
Est. Completion 2017-12
Phase NA

What the finished NCT02279303 record still lists

NCT02279303 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 2 interventions - of which Dietary Intervention is the first listed.

NCT02279303 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02279303 about?

NCT02279303 is a clinical study titled "Rx for Better Breast Health". This randomized controlled trial will test the impact of a patient-navigated, anti-inflammatory, culinary-based intervention (reinforced by motivational interviewing \[MI\] and tailored newsletters) on obese (body mass index \[BMI\] 30+), early-stage (0-IIIA) breast cancer survivors compared to a co...

What is the current status of trial NCT02279303?

This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2013-04. Estimated completion is 2017-12.

What interventions are being tested in trial NCT02279303?

The interventions under investigation include: Dietary Intervention (BEHAVIORAL), Dietary Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT02279303?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02279303's enrollment target sits among peer trials

153 656th of 2000 higher than 1,343 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05283265 · 153 participants · NA

    Neurophysiological Mechanisms of Language Comprehension

  • NCT05554393 · 153 participants · Phase 2

    Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

  • NCT05584501 · 153 participants · NA

    ETE Interventions in the Dental Setting

  • NCT05714839 · 153 participants · Phase 1

    A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02279303, the US trial registry maintained by the National Library of Medicine. NCT02279303 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.